1,085 results on '"Engstrøm, Thomas"'
Search Results
2. Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
3. Familial clustering of unexplained heart failure – A Danish nationwide cohort study
4. Time From Distress Call to Percutaneous Coronary Intervention and Outcomes in Myocardial Infarction
5. A Systematic Approach to the Evaluation of the Coronary Microcirculation Using Bolus Thermodilution: CATH CMD
6. Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
7. The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease
8. Prognostic differences between physiology-guided percutaneous coronary intervention and optimal medical therapy in coronary artery disease: A systematic review and meta-analysis
9. Rationale and design of the pullback pressure gradient (PPG) global registry
10. Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy
11. Impact of Post-PCI FFR Stratified by Coronary Artery
12. Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes
13. Optimal timing of influenza vaccination among patients with acute myocardial infarction – Findings from the IAMI trial
14. Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation – the third nordic aortic valve intervention trial – NOTION-3
15. Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial
16. Effect of Alirocumab on Carotid Inflammation by [18F]FDG PET in Patients with Acute Myocardial Infarction
17. The role of remnant cholesterol in patients with ST-segment elevation myocardial infarction
18. The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease
19. A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
20. The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
21. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
22. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial
23. Organized thrombus is a frequent underlying feature in culprit lesion morphology in non-ST-elevation myocardial infarction. A study using optical coherence tomography and magnetic resonance imaging
24. Prevalence and impact of frailty in patients ≥70 years old with acute coronary syndrome referred for coronary angiography
25. Is It Safe to Mobilize Patients Very Early After Transfemoral Coronary Procedures? (SAMOVAR): A Randomized Clinical Trial
26. Incidence, Predictors, and Outcome of In-Hospital Bleeding in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
27. Prognostic Value of Coronary CT Angiography in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
28. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
29. Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction
30. Discovery of plasma proteins associated with ventricular fibrillation during first ST-elevation myocardial infarction via proteomics.
31. Conductance artery stiffness impairs atrio-ventriculo-arterial coupling before manifestation of arterial hypertension or left ventricular hypertrophic remodelling
32. Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy
33. Jeopardized Myocardium and Survival in Patients Presenting to the Catheterization Laboratory With ST-Elevation Myocardial Infarction and Shock
34. Soluble urokinase receptor as a predictor of non-cardiac mortality in patients with percutaneous coronary intervention treated ST-segment elevation myocardial infarction
35. Evaluation and Management of Nonculprit Lesions in STEMI
36. Diagnostic Performance of Angiogram-Derived Fractional Flow Reserve: A Pooled Analysis of 5 Prospective Cohort Studies
37. Effect of the antipsychotic drug haloperidol on arrhythmias during acute myocardial infarction in a porcine model
38. Outcome in Elderly Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
39. Discovery of plasma proteins associated with ventricular fibrillation during first ST-elevation myocardial infarction via proteomics
40. Coronary CT Angiography as a Guide to Timing of Invasive Treatment in Patients With NSTEACS
41. Heart of the Matter in Complete ACS Revascularization
42. Instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality: iFR SWEDEHEART and DEFINE FLAIR
43. Variation in left and right coronary artery physiology in patients with severe aortic stenosis
44. Pre-Hospital Pulse Glucocorticoid Therapy in Patients with ST-Segment Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (PULSE-MI)
45. Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation
46. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
47. Rubidium-82 PET imaging is feasible in a rat myocardial infarction model
48. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
49. Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
50. Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.